{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:03:23Z","timestamp":1771261403448,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11845-023-03535-y","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:01:31Z","timestamp":1695877291000},"page":"837-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-life experience with plasmapheresis in newly diagnosed multiple myeloma accompanied by acute kidney injury"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-4680","authenticated-orcid":false,"given":"Pusem","family":"Patir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulay","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sait Emir","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Palak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Aykas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayca","family":"Inci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Karakus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Kurtoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"3535_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/107327481502200109","volume":"22","author":"LS Connelly-Smith","year":"2015","unstructured":"Connelly-Smith LS, Linenberger ML (2015) Therapeutic apheresis for patients with cancer. Cancer Control 22:60\u201378","journal-title":"Cancer Control"},{"key":"3535_CR2","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Kastritis E, Rosinol L et al (2008) Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 22:1485\u201393","DOI":"10.1038\/leu.2008.131"},{"issue":"1","key":"3535_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrneph.2011.168","volume":"8","author":"CA Hutchison","year":"2011","unstructured":"Hutchison CA, Batuman V, Behrens J et al (2011) The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 8(1):43\u201351","journal-title":"Nat Rev Nephrol"},{"key":"3535_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1158\/1078-0432.CCR-11-0498","volume":"18","author":"AA Chanan-Khan","year":"2012","unstructured":"Chanan-Khan AA, San Miguel JF, Jagannath S et al (2012) Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment. Clin Cancer Res 18:2145\u20132163","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3535_CR5","first-page":"207","volume":"56","author":"KC Abbott","year":"2001","unstructured":"Abbott KC, Agodoa LY (2001) Multiple myeloma and light chain-associated nephropathy in end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 56(3):207\u2013210","journal-title":"Clin Nephrol"},{"key":"3535_CR6","doi-asserted-by":"crossref","unstructured":"Uttervall K, Duru AD, Lund J et al (2014) The use of novel drugs can effectively improve response, delay relapse, and enhance overall survival in multiple myeloma patients with renal impairment. PLoS ONE 9(7):e101819","DOI":"10.1371\/journal.pone.0101819"},{"key":"3535_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ejim.2014.06.023","volume":"25","author":"L Rodrigues","year":"2014","unstructured":"Rodrigues L, Neves M, S\u00e1 H et al (2014) Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors. Eur J Intern Med 25:652\u2013656","journal-title":"Eur J Intern Med"},{"key":"3535_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/ndt\/gfp679","volume":"25","author":"DJ Tsakiris","year":"2012","unstructured":"Tsakiris DJ, Stel VS, Finne P et al (2012) Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA registry study. Nephrol Dial Transplant 25:1200\u20131206","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3535_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1681\/ASN.2014090876","volume":"27","author":"S Reule","year":"2013","unstructured":"Reule S, Sexton DJ, Solid CA et al (2013) End-stage renal disease due to multiple myeloma in the United States, 2001\u20132010. J Am Soc Nephrol 27(5):1487\u20131494","journal-title":"J Am Soc Nephrol"},{"key":"3535_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1161\/CIRCULATIONAHA.105.610642","volume":"114","author":"TD Smilde","year":"2006","unstructured":"Smilde TD, van Veldhuisen DJ, Navis G et al (2006) Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114:1572\u20131580","journal-title":"Circulation"},{"issue":"5","key":"3535_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","volume":"15","author":"G Norman","year":"2010","unstructured":"Norman G (2010) Likert scales, levels of measurement, and the \u201claws\u201d of statistics. Adv Health Sci Educ 15(5):625\u2013632","journal-title":"Adv Health Sci Educ"},{"issue":"6008","key":"3535_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/bmj.1.6008.503","volume":"1","author":"TG Feest","year":"1976","unstructured":"Feest TG, Burge PS, Cohen SL (1976) Successful treatment of myeloma kidney by diuresis and plasmapheresis. Br Med J 1(6008):503\u2013504","journal-title":"Br Med J"},{"issue":"6","key":"3535_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/ki.1988.127","volume":"33","author":"P Zucchelli","year":"1988","unstructured":"Zucchelli P, Pasquali S, Cagnoli L, Ferrari G (1988) Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33(6):1175\u20131180","journal-title":"Kidney Int"},{"key":"3535_CR14","doi-asserted-by":"crossref","unstructured":"Johnson WJ, Kyle RA, Pineda AA et al (1990) Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 150(4):863\u2013869","DOI":"10.1001\/archinte.150.4.863"},{"issue":"11","key":"3535_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","volume":"143","author":"WF Clark","year":"2005","unstructured":"Clark WF, Stewart AK, Rock GA et al (2005) Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 143(11):777\u2013784","journal-title":"Ann Intern Med"},{"key":"3535_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"key":"3535_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ki.2008.108","volume":"73","author":"N Leung","year":"2008","unstructured":"Leung N, Gertz MA, Zeldenrust SR et al (2008) Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on the reduction of serum free light chains. Kidney Int 73:1282\u20131288","journal-title":"Kidney Int"},{"key":"3535_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1681\/ASN.2010080857","volume":"22","author":"CA Hutchison","year":"2011","unstructured":"Hutchison CA, Cockwell P, Stringer S et al (2011) Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 22:1129\u20131136","journal-title":"J Am Soc Nephrol"},{"key":"3535_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1744-9987.12606","volume":"22","author":"V Premuzic","year":"2018","unstructured":"Premuzic V, Batinic J, Roncevic P et al (2018) Role of plasmapheresis in the management of acute kidney injury in patients with multiple myeloma: should we abandon it? Ther Apher Dial 22:79\u201386","journal-title":"Ther Apher Dial"},{"key":"3535_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S2352-3026(19)30014-6","volume":"6","author":"CA Hutchison","year":"2019","unstructured":"Hutchison CA, Cockwell P, Moroz V et al (2019) High cutoff versus high-flux hemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomized controlled trial. Lancet Haematol 6:217\u2013228","journal-title":"Lancet Haematol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03535-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03535-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03535-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T04:01:57Z","timestamp":1711339317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03535-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03535-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Local Ethics Committee of the University of Health Sciences Antalya Training and Research Hospital (16\/09\/2021\u201314\/12). This study was conducted in accordance with the 1964 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent was not sought from individual patients as retrospective information was available in the database, and no patient identifiers were used throughout the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent has been granted by all authors for the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}